Ophthalmology Times

ASRS 2026: Nearly 40% of patients with wet AMD go untreated for 180 days within the first year

New real-world data from ASRS 2026 show nearly 40% of wet AMD patients go 180+ days without anti-VEGF treatment within a year ...
Ophthalmology Times

ASRS 2026: MCO-010 optogenetic therapy sustains 3-line vision gains at 3 years in retinitis ...

REMAIN data show MCO-010 optogenetic therapy delivered durable ~3-line vision gains in retinitis pigmentosa regardless of ...